The General Office of the Xi'an Municipal People's Government issued the “Implementation Plan to Promote Capacity Enhancement in the Biomedical Industry”, which proposes to create superior products. In terms of traditional Chinese medicine, select and build a number of large varieties of traditional Chinese medicine with brand advantages. By 2027, 2 varieties with 1 billion yuan grade, 1 500 million yuan variety, 1 300 million yuan variety, and 3 100 million yuan varieties will be cultivated to expand the scale of “Qin Yao” superior products. In terms of chemicals, target drugs for liver delivery are encouraged to achieve large-scale mass production of innovative drugs, promote the industrialization process of Class I and Class II innovative drugs such as peptide products, cardiovascular products, and withdrawal products, and speed up the first generic drug to pass consistent evaluation of the quality and efficacy of generic drugs as soon as possible. In terms of medical devices, it supports R&D and production of X/gamma-ray radiotherapy equipment, PEEK skull repair products, blue laser surgical cutters, medical robots, and OCT imaging systems to further create superior products and expand market coverage.

The General Office of the Xi'an Municipal People's Government issued the “Implementation Plan to Promote Capacity Enhancement in the Biomedical Industry”, which proposes to create superior products. In terms of traditional Chinese medicine, select and build a number of large varieties of traditional Chinese medicine with brand advantages. By 2027, 2 varieties with 1 billion yuan grade, 1 500 million yuan variety, 1 300 million yuan variety, and 3 100 million yuan varieties will be cultivated to expand the scale of “Qin Yao” superior products. In terms of chemicals, target drugs for liver delivery are encouraged to achieve large-scale mass production of innovative drugs, promote the industrialization process of Class I and Class II innovative drugs such as peptide products, cardiovascular products, and withdrawal products, and speed up the first generic drug to pass consistent evaluation of the quality and efficacy of generic drugs as soon as possible. In terms of medical devices, it supports R&D and production of X/gamma-ray radiotherapy equipment, PEEK skull repair products, blue laser surgical cutters, medical robots, and OCT imaging systems to further create superior products and expand market coverage.